Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
A synergetic effect of BARD1 mutations on tumorigenesis
Wenjing Li et al.
NATURE COMMUNICATIONS (2021)
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
Usha Menon et al.
LANCET (2021)
Clinical cancer genomic profiling
Debyani Chakravarty et al.
NATURE REVIEWS GENETICS (2021)
A single-cell and spatially resolved atlas of human breast cancers
Sunny Z. Wu et al.
NATURE GENETICS (2021)
Spatial omics and multiplexed imaging to explore cancer biology
Sabrina M. Lewis et al.
NATURE METHODS (2021)
Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics
Sophia K. Longo et al.
NATURE REVIEWS GENETICS (2021)
Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis
Qi Cui et al.
NATURE CANCER (2021)
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer
Lara Paracchini et al.
CLINICAL CANCER RESEARCH (2021)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation
Jinghui Song et al.
NATURE CHEMICAL BIOLOGY (2020)
Pan-genomics in the human genome era
Rachel M. Sherman et al.
NATURE REVIEWS GENETICS (2020)
The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
Tao Liu et al.
NUCLEIC ACIDS RESEARCH (2020)
Assessing aneuploidy with repetitive element sequencing
Christopher Douville et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer
Sanghoon Lee et al.
CELL REPORTS (2020)
A single-cell landscape of high-grade serous ovarian cancer
Benjamin Izar et al.
NATURE MEDICINE (2020)
Poly(ADP-ribose) polymerase inhibition: past, present and future
Nicola J. Curtin et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma
Yingwei Hu et al.
CELL REPORTS (2020)
Regulating tumor suppressor genes: post-translational modifications
Ling Chen et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Epithelial ovarian cancer
Stephanie Lheureux et al.
LANCET (2019)
Integrative single-cell analysis
Tim Stuart et al.
NATURE REVIEWS GENETICS (2019)
Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers
Eiryo Kawakami et al.
CLINICAL CANCER RESEARCH (2019)
A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer
Qiujin Shen et al.
EBIOMEDICINE (2019)
BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Kevin K. Lin et al.
CANCER DISCOVERY (2019)
Detection of post-translational modifications using solid-phase proximity ligation assay
Felipe Marques Souza de Oliveira et al.
NEW BIOTECHNOLOGY (2018)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells
Nicola Guzzi et al.
CELL (2018)
Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
Rebecca C. Arend et al.
MOLECULAR CANCER RESEARCH (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers
Yuxuan Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Accurate classification of BRCA1 variants with saturation genome editing
Gregory M. Findlay et al.
NATURE (2018)
Copy number signatures and mutational processes in ovarian carcinoma
Geoff Macintyre et al.
NATURE GENETICS (2018)
Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration
Makoto Nakabayashi et al.
SCIENTIFIC REPORTS (2018)
Integrated extracellular microRNA profiling for ovarian cancer screening
Akira Yokoi et al.
NATURE COMMUNICATIONS (2018)
Artificial intelligence in healthcare
Kun-Hsing Yu et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions
Thomas R. Pisanic et al.
CLINICAL CANCER RESEARCH (2018)
Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses
Adriaan Vanderstichele et al.
CLINICAL CANCER RESEARCH (2017)
ADPriboDB: The database of ADP-ribosylated proteins
Christina A. Vivelo et al.
NUCLEIC ACIDS RESEARCH (2017)
Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction
Michelle R. Jones et al.
GYNECOLOGIC ONCOLOGY (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study
Adam N. Rosenthal et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer
Elizabeth L. Christie et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Genomic approaches to accelerate cancer interception
Jennifer Beane et al.
LANCET ONCOLOGY (2017)
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
Yi Kan Wang et al.
NATURE GENETICS (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
High grade serous ovarian carcinomas originate in the fallopian tube
S. Intidhar Labidi-Galy et al.
NATURE COMMUNICATIONS (2017)
The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
Martin Widschwendter et al.
GENOME MEDICINE (2017)
Dynamic RNA Modifications in Gene Expression Regulation
Ian A. Roundtree et al.
CELL (2017)
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts
Paola Todeschini et al.
CANCER LETTERS (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden et al.
CELL (2017)
Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses
Robert L. Coleman et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Hui Zhang et al.
CELL (2016)
Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors
Matthew F. Buas et al.
GYNECOLOGIC ONCOLOGY (2016)
Multiple Reaction Monitoring for Direct Quantitation of Intact Proteins Using a Triple Quadrupole Mass Spectrometer
Evelyn H. Wang et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2016)
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
Ian J. Jacobs et al.
LANCET (2016)
Integrated digital error suppression for improved detection of circulating tumor DNA
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2016)
Ovarian cancer
Ursula A. Matulonis et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer
Huan Wang et al.
SCIENTIFIC REPORTS (2016)
N6-methyladenosine Modulates Messenger RNA Translation Efficiency
Xiao Wang et al.
CELL (2015)
Efficient molecular subtype classification of high-grade serous ovarian cancer
Huei San Leong et al.
JOURNAL OF PATHOLOGY (2015)
The Promise of Proteomics for the Study of ADP-Ribosylation
Florian J. Bock et al.
MOLECULAR CELL (2015)
The emerging role of IncRNAs in cancer
Maite Huarte
NATURE MEDICINE (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Xiaojing Yang et al.
CANCER CELL (2014)
Transcriptome-wide Mapping Reveals Widespread Dynamic-Regulated Pseudouridylation of ncRNA and mRNA
Schraga Schwartz et al.
CELL (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
Gottfried E. Konecny et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
R. J. Kurman
ANNALS OF ONCOLOGY (2013)
A High-Throughput Functional Complementation Assay for Classification of BRCA1 Missense Variants
Peter Bouwman et al.
CANCER DISCOVERY (2013)
Mass spectrometry-based proteomics: existing capabilities and future directions
Thomas E. Angel et al.
CHEMICAL SOCIETY REVIEWS (2012)
Modular regulatory principles of large non-coding RNAs
Mitchell Guttman et al.
NATURE (2012)
Landscape of transcription in human cells
Sarah Djebali et al.
NATURE (2012)
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dan Dominissini et al.
NATURE (2012)
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Rohini Roy et al.
NATURE REVIEWS CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors
Frederick R. Ueland et al.
OBSTETRICS AND GYNECOLOGY (2011)
Human transcriptome array for high-throughput clinical studies
Weihong Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
Richard G. Moore et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared In Vitro Diagnostic Multivariate Index Assay of Proteomic Biomarkers
Zhen Zhang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
ADP-ribose polymer - a novel and general biomarker of human cancers of head & neck, breast, and cervix
Rennie O. Lakadong et al.
MOLECULAR CANCER (2010)
International network of cancer genome projects
Thomas J. Hudson et al.
NATURE (2010)
Post-translational modifications in signal integration
Yonathan Lissanu Deribe et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Protein detection using proximity-dependent DNA ligation assays
S Fredriksson et al.
NATURE BIOTECHNOLOGY (2002)
Share Paper
